Trending: GSK, Sanofi in Focus After U.S. Judge Dismisses Zantac Lawsuit
08 December 2022 - 02:08AM
Dow Jones News
9:38 ET -- GSK PLC and Sanofi SA are among the most talked about
companies in the U.S. across all news items in the last 12 hours,
according to Factiva data. A U.S. judge dismissed a series of
lawsuits, numbering in the tens of thousands, around the Zantac
heartburn treatment that both GSK and Sanofi had marketed. The
judge in a multidistrict ruling concluded there was no scientific
evidence to support the claim Zantac's active ingredient was
carcinogenic. The decision could be appealed. U.S.-traded shares of
GSK and Sanofi opened roughly 0.9% and 1.8% lower, respectively.
Dow Jones & Co. owns Factiva. (robb.stewart@wsj.com)
(END) Dow Jones Newswires
December 07, 2022 09:53 ET (14:53 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Sanofi (EU:SAN)
Historical Stock Chart
From Feb 2024 to Mar 2024
Sanofi (EU:SAN)
Historical Stock Chart
From Mar 2023 to Mar 2024